Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition with effect of reducing uric acid as well as preparation method and purpose thereof

A technology of composition and medicine, which is applied in the field of pharmaceutical composition with uric acid-lowering effect and its preparation, can solve the problems of high cost of raw materials and complex composition of raw materials, and achieve the effect of simple composition, low cost and significant effect

Inactive Publication Date: 2018-03-06
CATCH BIO SCI & TECH
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned composition has disadvantages such as complex raw material composition and high raw material cost, which limit its application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition with effect of reducing uric acid as well as preparation method and purpose thereof
  • Medicine composition with effect of reducing uric acid as well as preparation method and purpose thereof
  • Medicine composition with effect of reducing uric acid as well as preparation method and purpose thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] The raw materials of the pharmaceutical composition in this embodiment consist of: 35g of vine tea extract, 10g of Clematis clematis extract, 30g of honeysuckle vine extract, 19g of lovage extract, 6g of Lonicerae extract;

[0054] The preparation method of the pharmaceutical composition comprises the following steps: taking selected weights of vine tea extract, Clematis clematis extract, honeysuckle vine extract, lovage extract and scorpion extract respectively, grinding and mixing uniformly to obtain the product.

[0055] The pharmaceutical composition of this embodiment is prepared into tablets by adding conventional excipients and following conventional techniques.

Embodiment 2

[0057] The raw materials of the pharmaceutical composition in this embodiment consist of: vine tea extract 25g, Clematis clematis extract 22g, honeysuckle vine extract 7g, lovage extract 29g, sage extract 17g;

[0058] The preparation method of the pharmaceutical composition comprises the following steps: taking selected weights of vine tea extract, Clematis clematis extract, honeysuckle vine extract, lovage extract and scorpion extract respectively, grinding and mixing uniformly to obtain the product.

[0059] The pharmaceutical composition of this embodiment is prepared into capsules by adding conventional excipients and following conventional techniques.

Embodiment 3

[0061] The raw materials of the pharmaceutical composition in this embodiment consist of: vine tea extract 13g, Clematis clematis extract 34g, honeysuckle vine extract 19g, lovage extract 7g, sage extract 27g;

[0062] The preparation method of the pharmaceutical composition comprises the following steps: taking selected weights of vine tea extract, Clematis clematis extract, honeysuckle vine extract, lovage extract and scorpion extract respectively, grinding and mixing uniformly to obtain the product.

[0063] The pharmaceutical composition of this embodiment is prepared into an oral liquid by adding conventional excipients and following a conventional process.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the fields of medicines, health care products or food, and in particular relates to a pharmaceutical composition with the effect of lowering uric acid, a preparation method and application thereof. The raw materials of the pharmaceutical composition include: 5-50 parts by weight of vine tea extract, 1-45 parts by weight of Clematis clematis extract, 2-49 parts by weight of honeysuckle vine extract, 1-40 parts by weight of lovage extract, 0.5-32 parts by weight of the extract. The present invention fully considers the composition of raw materials and the ratio of each raw drug, so that each raw drug cooperates and acts together under a specific ratio, thereby exerting the effect of lowering uric acid; the pharmaceutical composition not only has significant The uric acid-lowering effect has less toxic and side effects and higher safety; the pharmaceutical composition only includes 5 kinds of raw materials, and the composition is simple and the cost is low.

Description

technical field [0001] The invention belongs to the field of medicines, health care products or food, and in particular relates to a pharmaceutical composition with the effect of lowering uric acid, a preparation method and application thereof. Background technique [0002] Gout is a crystal-associated arthropathy caused by the deposition of monosodium urate (MSU), which is directly related to hyperuricemia caused by purine metabolic disorders and / or decreased uric acid excretion. The main clinical manifestation is hyperuricemia , Gouty acute arthritis recurrent attacks, gouty chronic arthritis and tophi, gouty nephropathy and renal uric acid stones, etc. Gout specifically refers to acute characteristic arthritis and chronic tophi diseases, mainly including acute onset arthritis, tophi formation, tophi chronic arthritis, urate nephropathy and uric acid urolithiasis, and joint disability may occur in severe cases and renal insufficiency; in addition, gout is often accompanie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8945A61P19/06A23L33/105
CPCA61K36/87A23V2002/00A61K36/232A61K36/355A61K36/716A61K36/8945A61K2300/00A23V2200/30A23V2250/21
Inventor 温尧林
Owner CATCH BIO SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com